Selected article for: "China spread and expectoration cough"

Author: Yang, Jiazhao; Wu, Kerong; Ding, Ao; Li, Li; Lu, Hui; Zhu, Wanbo; Xie, Kai; Yao, Ziqin; Fang, Shiyuan
Title: Clinical characteristics, treatment, and prognosis of 74 2019 novel coronavirus disease patients in Hefei: A single-center retrospective study
  • Cord-id: zmlvl2lw
  • Document date: 2021_5_28
  • ID: zmlvl2lw
    Snippet: Since December 2019, pneumonia caused by a novel coronavirus (SARS-CoV-2), namely 2019 novel coronavirus disease (COVID-19), has rapidly spread from Wuhan city to other cities across China. The present study was designed to describe the epidemiology, clinical characteristics, treatment, and prognosis of 74 hospitalized patients with COVID-19. Clinical data of 74 COVID-19 patients were collected to analyze the epidemiological, demographic, laboratory, radiological, and treatment data. Thirty-two
    Document: Since December 2019, pneumonia caused by a novel coronavirus (SARS-CoV-2), namely 2019 novel coronavirus disease (COVID-19), has rapidly spread from Wuhan city to other cities across China. The present study was designed to describe the epidemiology, clinical characteristics, treatment, and prognosis of 74 hospitalized patients with COVID-19. Clinical data of 74 COVID-19 patients were collected to analyze the epidemiological, demographic, laboratory, radiological, and treatment data. Thirty-two patients were followed up and tested for the presence of the viral nucleic acid and by pulmonary computed tomography (CT) scan at 7 and 14 days after they were discharged. Among all COVID-19 patients, the median incubation period for patients and the median period from symptom onset to admission was all 6 days; the median length of hospitalization was 13 days. Fever symptoms were presented in 83.78% of the patients, and the second most common symptom was cough (74.32%), followed by fatigue and expectoration (27.03%). Inflammatory indicators, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) of the intensive care unit (ICU) patients were significantly higher than that of the non-ICU patients (P < .05). However, 50.00% of the ICU patients had their the ratio of T helper cells to cytotoxic T cells (CD4/CD8) ratio lower than 1.1, whose proportion is much higher than that in non-ICU patients (P < .01). Compared with patients in Wuhan, COVID-19 patients in Anhui Province seemed to have milder symptoms of infection, suggesting that there may be some regional differences in the transmission of SARS-CoV-2 between different cities.

    Search related documents:
    Co phrase search for related documents
    • acid testing and admission patient: 1, 2, 3, 4
    • acid testing and lung infection: 1, 2, 3, 4
    • acid testing and lung involvement: 1, 2, 3
    • acid testing and lymphopenia patient: 1
    • acute respiratory distress syndrome and admission patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and admit patient: 1
    • acute respiratory distress syndrome and local center: 1, 2
    • acute respiratory distress syndrome and local hospital: 1, 2, 3, 4, 5, 6
    • acute respiratory distress syndrome and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and lymphopenia patient: 1
    • acute respiratory distress syndrome patient and admission patient: 1, 2, 3, 4, 5, 6, 7
    • acute respiratory distress syndrome patient and local hospital: 1
    • acute respiratory distress syndrome patient and lung infection: 1, 2
    • acute respiratory distress syndrome patient and lung involvement: 1
    • admission patient and local hospital: 1, 2, 3, 4
    • admission patient and lung infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • admission patient and lung involvement: 1, 2, 3, 4, 5, 6, 7, 8
    • admission patient and lymphopenia patient: 1, 2, 3, 4